首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   16174篇
  免费   6189篇
  国内免费   68篇
耳鼻咽喉   317篇
儿科学   449篇
妇产科学   420篇
基础医学   219篇
口腔科学   1390篇
临床医学   6029篇
内科学   3807篇
皮肤病学   557篇
神经病学   2173篇
特种医学   511篇
外科学   2278篇
综合类   26篇
现状与发展   2篇
预防医学   2425篇
眼科学   357篇
药学   153篇
中国医学   1篇
肿瘤学   1317篇
  2024年   142篇
  2023年   1284篇
  2022年   290篇
  2021年   636篇
  2020年   1106篇
  2019年   448篇
  2018年   1452篇
  2017年   1617篇
  2016年   1594篇
  2015年   1629篇
  2014年   1856篇
  2013年   1801篇
  2012年   616篇
  2011年   642篇
  2010年   1074篇
  2009年   1444篇
  2008年   519篇
  2007年   339篇
  2006年   440篇
  2005年   247篇
  2004年   197篇
  2003年   168篇
  2002年   130篇
  2001年   271篇
  2000年   126篇
  1999年   226篇
  1998年   272篇
  1997年   290篇
  1996年   287篇
  1995年   249篇
  1994年   157篇
  1993年   144篇
  1992年   106篇
  1991年   85篇
  1990年   64篇
  1989年   86篇
  1988年   67篇
  1987年   49篇
  1986年   43篇
  1985年   46篇
  1984年   33篇
  1983年   23篇
  1982年   22篇
  1981年   18篇
  1980年   15篇
  1979年   8篇
  1978年   13篇
  1977年   10篇
  1976年   8篇
  1971年   9篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Although depression is associated to physical discomfort, meanings of the body in depression are rarely addressed in clinical research. Drawing on the concept of the lived body, this study explores depression as an embodied phenomenon. Using a hermeneutic phenomenological approach, the analysis of narrative‐based interviews with 11 depressed adults discloses a thematic structure of an embodied process of an ambiguous striving against fading. Five subthemes elicit different dimensions of this process, interpreted as disabling or enabling: feeling estranged, feeling confined, feeling burdensome, sensing life and seeking belongingness. In relation to clinical practice, we suggest that the interdisciplinary team can focus on enhancing the enabling dimensions, for example through guided physical activities to support the patient to feel more alive, capable and connected. Moreover, we suggest that the treatment process benefits from an increased awareness of the ambiguity in the patient's struggle, acknowledging both destructive and recharging elements of the withdrawing, and the perceived conflict in‐between.  相似文献   
3.
4.
5.
6.
7.

Background

Refractory acute myeloid leukemia (AML) includes AML includes failure of disease to respond to standard induction chemotherapy, relapse within 6 months after first CR, and 2 or more relapses. The outcome of these patients is usually very poor; only a small proportion can be rescued by allogenic hematopoietic stem-cell transplantation (allo-HSCT). The aim of this study was to evaluate the efficacy and feasibility of allo-HSCT in patients with refractory AML.

Patients and Methods

We retrospectively analyzed the clinical outcome of 91 patients who were diagnosed with treatment-refractory AML at Hacettepe University Hospital between January 2002 and June 2018. Patients' disease status included refractory AML, defined as failure to respond to standard induction chemotherapy and relapse within 6 months after first complete remission.

Results

The median follow-up was 12 months (range, 0.5-184 months) for the entire group. Kaplan-Meier estimates of the 3-year overall survival for patients who underwent allo-HSCT and patients who received only salvage chemotherapy were 67% and 12%, respectively. Additionally, the Kaplan-Meier estimates of 5-year overall survival for patients who underwent allo-HSCT and patients who received only salvage chemotherapy were 44% and 4%, respectively (P < .001). Complete remission was obtained in 25 patients (83.3%) who underwent allo-HSCT; however, the disease of only 3 patients (3.8%) exhibited complete response after salvage chemotherapy.

Conclusion

Allo-HSCT is still the best-known treatment option with curative potential in patients with treatment-refractory AML. Therefore, all efforts should be made in an attempt to find a suitable matched donor in order to perform allo-HSCT.  相似文献   
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号